07 March 2014 : Research paper
Infant mortality and life expectancy in China
Yanhua XuABCDEF, Weifang ZhangB, Rulai YangB, Chaochun ZouB, Zhengyan ZhaoAGDOI: 10.12659/MSM.890204
Med Sci Monit 2014; 20:379-385
Abstract
BACKGROUND: It is reported that the infant mortality (IM) rate decreased rapidly in China and the life expectancy (LE) also had a high increase. Our objective was to determine the health status of the Chinese population by investigating IM and LE and their inter-relationship.
MATERIAL AND METHODS: Based on a literature review on the history and current status of IM and LE in China and other major countries, the relationship between IM, LE, and per capita gross national income (GNI) was investigated in 2013.
RESULTS: The decline in IM from 30% to 15% took China only 7 years, which was faster than in developed countries. The leading causes of infant death in China were perinatal diseases, infectious and parasitic diseases, congenital anomalies, accidents, and signs, symptoms, and ill-defined conditions. Most under-5 mortality occurred during infancy (80%), particularly during the neonatal period (55%). LE was negatively correlated with IM (r=–0.921, P<0.001) and per capita GNI (r=0.778, P<0.001), while IM was negatively correlated with per capita GNI (r=–0.735, P<0.001). However, healthcare capabilities and per capita GNI in China are still below the level of developing countries. Some countries have a comparable IM and healthcare capabilities, but they have a much higher per capita GNI than China.
CONCLUSIONS: In China, IM has decreased and IE increased rapidly. However, they were not in parallel with the current economic development. Deviation of these data might be attributed to many factors. In-house surveys and hospital-based follow-ups should be carried out to better understand infant death.
Keywords: Life Expectancy, Infant Mortality, Cause of Death, Child, Preschool, China - epidemiology, Delivery of Health Care - utilization, Internationality, Public Health - economics, Time Factors
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
26 Feb 2024 : Clinical Research
Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...Med Sci Monit In Press; DOI: 10.12659/MSM.942509
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952